Insights

Field stories, evidence, and what's next in lung health AI.

Case studies from active deployments, peer-reviewed evidence, and reflections from the team building chest X-ray AI for healthcare programmes worldwide.

Global impact

Real-world impact: screening the underserved at scale

How Nexus AI CXR is enabling over 20,000 annual mobile and fixed-clinic screenings in partnership with the Global Fund and World Vision – accelerating early TB detection.

Continue reading →
Industry insights

Beyond imaging: integrating LLMs into the radiology workflow

Large language models are emerging as the next layer in chest X-ray AI. Our take on how LLMs extend triage with context-aware summaries – and why Nexus is keeping it firmly in Beta.

Continue reading →
Clinical innovation

The new standard in lung health: Nexus AI achieves CE MDR Class IIb certification

A milestone moment for Nexus. What CE MDR Class IIb actually means for the product, for procurement, and for the customers and patients we serve.

Continue reading →
Occupational health

Nexus Intelligence redefines the boundaries of medical diagnostics with world-first AI deployment 4km underground

How Nexus AI is pushing the limits of medical diagnostics by bringing life-saving AI to the most extreme environments on Earth, including Mponeng Gold Mine, the deepest point on Earth where such technology has ever been operational.

Continue reading →
Evidence

Prospective multi-site validation of AI to detect tuberculosis and chest X-ray abnormalities

The peer-reviewed evaluation behind our TB model – 0.897 AUC, ranked 2nd of 12 CAD AI vendors, validated against the South African National TB Prevalence Survey.

Read in The Lancet →
Product news

Multi-Pathology Beta: where transparency meets innovation

Our approach to advancing beyond TB: why we're keeping the multi-pathology layer firmly in Beta, what's in the regulatory pipeline, and how customers can responsibly evaluate it.

Read the approach →